Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of postoperative delirium after thoracoscopic lung cancer surgery in elderly patients with fragile brain function
ChiCTR2400083811Phase 4Recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative delirium (POD) and bronchial carcinoma (2 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoints: Incidence of postoperative delirium, Serum interleukin-6 (IL-6) and 1 more. Started May 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative delirium (POD)bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2400083811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083811.